Acquire shares

CStone Pharmaceuticals on Tuesday announced that its CEO Jason Yang plans to buy up to HK$5 million worth of the company’s shares in the open market over the next six months.

FAST NEWS: CStone says CEO to boost company holdings

The latest: CStone Pharmaceuticals (2616.HK) on Tuesday announced that its CEO Jason Yang plans to buy up to HK$5 million ($640,000) worth of the company’s shares in the open market over the…
2616.HK

Recent Articles

RELATED ARTICLES

  1. Earnings blow for CSPC Pharma
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  2. East Buy ends superstar influencer addiction – but at a big price
    1797.HK
  3. Xuanzhu Biopharm set for spin-off in Hong Kong IPO
    0460.HK
  4. Hengrui Pharma accelerates bid for global brand status
    600276.SHG
  5. Mao Geping’s Hong Kong IPO gets lift from regulatory nod
  6. ATRenew launches major store expansion to raise service accessibility, company profile
    RERE.US
  7. Jiayin cashes in on China’s efforts to boost consumer spending 
    JFIN.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva